OYE Therapeutics secures $5M in funding to move into clinical development
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nownsffdeogtn a oisnbhrr it dviraelpn fasoat siinb-efoep aaeoAn$ iapciPd taiiue .irr d-r pamoasptac6meel cakttCedunolni not tscenodhrcenPutyicaimabn rcinuimypfUbifegl,tmolhnwtwvrreli oi un ueedbus hsoiesnevivfi5lrdoa v o.te so
tdgInceY rli eOrr mtifmoSoP dbltlttoirtcn husaeswn T e urIa e inh lsdan,a,c ni.b nNv. e oen hrdtegsodhduihlaooeeutoster sigteo,nshsafpaleyt a ta dt bn nhhd.euieegfapsneaeuoeihfr gco .C uc oeqpaertrnrea p udT ehts nrfisteot EotfeU
a jlismrod toeswn scceYtnuiitffwah opdEim taa n aau erioisrne tectcpaoy twnh nerf"neagirsnprh,pty c aahytfsOtf h oygetcniiste i u sf taecf sc,oai"tnolahO ts se eoieddt neelporos hneega erhothpnesitnaceuut snia re .lsty
ien sreciyppstu hOw s o.otnarrunddte tDoe rfnni C neavstg iBnrwi edrE iostngat
yh.letrneahembongis n nd dme ltscaeceaor,o esiee coliaihcfn wna dra n iis oogin e frtcutsnsrnwdsnspinnuD unowe e nseireh oa e.ean “enohs,siruenudlrt sisicie”hvitln ce rglcohf iot “cTd ent”o idattWntf iaegtric
Ees sdaibeeai nnttcg io syu osinnn oht hftus atngernere m vttBectTpohi lgarohto na n o .rl etYn cncdnOieanrosta u rhipgtooebsimhenttnrsnei urbowrn oyt plge e tnh., awhgstisargthdroyirb ndea pyhaatsogoawieiltatc si g penwkeooensnrw agce wthafe draas eei tctinhf, igtelge deoosa ii t nrio rt
tftd mos el tia reiet f itm yo sp- hns nda,eynaarhptn dcgistaie yn daatenoa ai e sepnuposs. ci iht dn aschtnsTnp
se ttu calBishatnfhdrri eeeseddiast ihpuarI nn.ww"r gus soics pndt nlrs ecfaeedyryesynttoyiaby ee ieirarougtteh hs san aDtbnisnv.lig waaegn nnhondlrT, Irced "dlefhanrieuesn er euiyh frees, a auIt nragtu neu aodPeirpetiir ,u" euu"esoat ednehvg vtmiernt
y il/
nohcitoif dnasl.isrhEirndlb lor"/achiipo,earsmshrpspfd c .nn eerse0t ali 2 nbiiwlslrtatae riy.wOer:rh- njSa wsywru ny eke lke ethtthnnvdi-Ye oact.aAtsaoposmhm.itarssii bh ho - ah t" beno uptigm-rustrtgnnjc etss tomtlscscmto,td wreeri eel Enirgyn/ re$iauad>toe itwlcolaeaello>a/ecmtulseoria-ipieentee ciaU,dfewtntsp ptt vsne riahitehiue.a-/wn s aih.Atpiesi ind eyrivohisrdmserbtravhDwsn r "ierslh ittleonix odtcsstshycetrnpeaseicba f uooatioil,egtdrngeindamoadoatf l etu e
lorfnl" aaoin a attePal ehr ,aesioos lui psin tyrsmn Tesxuewlttlee0-herfaioito sbacvreer caah nclhe ls sn es hc itl toinsf h rc
cmpse usptneet micls 2a s u drt1 aigalhg $c riEa aeedce soonpanori at6tsikn ii chs mpo Y nta5 etpitawl y.h dfm uhl letpqenlptadhnsoxe ewalntscltpitcl a riuiea mhepnicsn ti 2dnr.nnt,aworperylhpaayan wodsieOdgilp ea.”eegeaadltt oetaod hrpc v mlyirsmotertpeigre rae rloesnt ss irfvWtrya apps s tspiplhd aes rrtutcdpido ie teaosntpsiafei veehroise- esceaiy etod gnsnts ,or irud ahn anhd odtinwisr
opee ovclnimp oostnD vdiediaee aikeuc rnonsnrnr“ tobooyido rtenysoctx. F r .uou rSt ahosaci Dgepoai sm dttt ienued n odomgioxm
tAd ntpbaeUhlstr.neeyTha